CompanyGraph
What stands out
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $21.97M, above the global median of $16.24M
- FinancialsAltman Z-Score 3.66: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Pays more per share than it earned over the last twelve months
Dividends view
Yield
1.47%Above 5Y avg (1.39%)
Annual Rate
CNY 0.10Paid annual
Payout Ratio
105.6%High
Payback Period
66.4 yr
Last Ex-Dividend
Jun 17, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.23BCNY627.17M · vs all stocks (USD)
Trailing P/E
76.00xRevenue (TTM)
3.16BCNY468.03M · vs all stocks (USD)
Profit Margin
1.87%Beta
0.2150xvs all stocks
52-Week Change
-6.08%vs all stocks
Market Capitalization
4.23BCNY627.17M · vs all stocks (USD)
Enterprise Value
2.62BCNY388.54M · vs all stocks (USD)
Trailing P/E
76.00xForward P/E
19.00xPrice to Sales (TTM)
1.35xPrice to Book (MRQ)
1.12xEnterprise to Revenue
0.8300xEnterprise to EBITDA
15.66xGross Margin
21.51%Profit Margin
1.87%Operating Margin
2.61%Return on Assets (TTM)
0.28%Return on Equity (TTM)
1.15%Revenue (TTM)
3.16BCNY468.03M · vs all stocks (USD)
Revenue per Share (TTM)
5.07CNYUpdated Aug 18, 2026Quarterly Revenue Growth
-5.10%Gross Profit (TTM)
674.45MCNY100.02M · vs all stocks (USD)
EBITDA (TTM)
240.86MCNY35.72M · vs all stocks (USD)
Net Income (TTM)
58.94MCNY8.74M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
21.80%Operating Cash Flow (TTM)
230.92MCNY34.25M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
148.16MCNY21.97M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1000CNYUpdated Aug 18, 2026Trailing Annual Dividend Yield
1.47%vs all stocks
5-Year Average Dividend Yield
1.39%vs all stocks
Payout Ratio
105.60%Minority Interest (Equity)
1.04BCNYFY2025 · Dec 31, 2025Revenue
3.20BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
2.53BCNYFY2025 · Dec 31, 2025Gross Profit
666.98MCNYFY2025 · Dec 31, 2025Operating Income
36.23MCNY5.37M · vs all stocks (USD)
Pre-tax Income
65.19MCNYFY2025 · Dec 31, 2025Income Tax Expense
13.90MCNYFY2025 · Dec 31, 2025Net Income
51.29MCNYFY2025 · Dec 31, 2025EBIT
70.40MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
240.86MCNYFY2025 · Dec 31, 2025Research & Development
110.14MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
180.05MCNYFY2025 · Dec 31, 2025Other Operating Expenses
23.00MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
19.18MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
5.21MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.0867CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.0867CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
621.85MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
621.85MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
51.29MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
2.62MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
99.98MCNYFY2025 · Dec 31, 2025Free Cash Flow
-57.77MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.36BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
51.29MCNYFY2025 · Dec 31, 2025Other Non-cash Items
8.48MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
5.12MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
35.08MCNYFY2025 · Dec 31, 2025Capital Expenditures
-157.75MCNYFY2025 · Dec 31, 2025Net Acquisitions
0.00CNYFY2025 · Dec 31, 2025Purchase of Investments
-1.34BCNYFY2025 · Dec 31, 2025Sale of Investments
1.18BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-309.41MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00CNYFY2025 · Dec 31, 2025Long-term Debt Payments
0.00CNYFY2025 · Dec 31, 2025Common Dividends Paid
-67.51MCNYFY2025 · Dec 31, 2025Other Financing Charges
-7.35MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-74.86MCNYFY2025 · Dec 31, 2025Shares Outstanding
621.92MSharesUpdated Aug 18, 2026Float Shares
333.36MSharesUpdated Aug 18, 2026% Held by Insiders
50.84%vs all stocks
% Held by Institutions
0.91%vs all stocks
Total Cash (MRQ)
2.77BCNY410.27M · vs all stocks (USD)
Total Cash per Share (MRQ)
4.45CNYUpdated Aug 18, 2026Total Debt (MRQ)
192.17MCNY28.50M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0396xCurrent Ratio (MRQ)
3.93xBook Value per Share (MRQ)
6.12CNYUpdated Aug 18, 2026Total Assets
6.01BCNY890.81M · vs all stocks (USD)
Total Current Assets
3.80BCNYFY2025 · Dec 31, 2025Total Liabilities
1.18BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.21BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
208.77MCNYFY2025 · Dec 31, 2025Total Current Liabilities
975.95MCNYFY2025 · Dec 31, 2025Cash
1.49BCNYFY2025 · Dec 31, 2025Cash Equivalents
24.25MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.52BCNYFY2025 · Dec 31, 2025Other Short-term Investments
939.31MCNYFY2025 · Dec 31, 2025Accounts Receivable
408.12MCNYFY2025 · Dec 31, 2025Inventory
233.14MCNYFY2025 · Dec 31, 2025Accounts Payable
554.97MCNYFY2025 · Dec 31, 2025Short-term Debt
8.74MCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.10MCNYFY2025 · Dec 31, 2025Long-term Debt
183.08MCNYFY2025 · Dec 31, 2025Common Stock (Book)
621.92MCNYFY2025 · Dec 31, 2025Retained Earnings
1.64BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
4.82BCNY715.12M · vs all stocks (USD)
Treasury Stock
0.00CNYFY2025 · Dec 31, 202552-Week Low
5.67CNYUpdated Aug 18, 202652-Week High
9.80CNYUpdated Aug 18, 202652-Week Change
-6.08%vs all stocks
Beta
0.2150xvs all stocks
50-Day MA
6.21CNYUpdated Aug 18, 2026200-Day MA
7.09CNYUpdated Aug 18, 2026Avg 10-Day Volume
15.32MSharesUpdated Aug 18, 2026Avg 30-Day Volume
14.04MSharesUpdated Aug 18, 2026Diluted EPS (TTM)
0.0900CNYUpdated Aug 18, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash Backing With OCF Coverage And Cash Near Total Debt
Cash on hand covers most or all of its total debt, and cash flow matches reported earnings.
Reads
How is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 1.06Dividend per Share: 0.10Earnings per Share: 0.09
Financial Health
Altman Z-Score 3.66: safe zoneNotable
Altman Z-Score: 3.66
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $21.97M, above the global median of $16.24MNotable
Levered free cash flow (USD): 21,971,883.602Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Cerus Corporation
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Kinetic Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Lanzhou Foci Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tibet Weixinkang Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Gkht Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hangzhou AGS Medtech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Ironwood Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Kexing Biopharm Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
TTY Biopharm Company Limited
Tier 1ProductionApproval-Gated PipelineRule
Beijing Scitop Bio-Tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Hangzhou iEcho Science & Technology Co., Ltd.
2 interpretationsClose Below 40W SMA With ProfitabilityCash Backing With OCF Coverage And Cash Near Total Debt
Lao Feng Xiang Co., Ltd.
2 interpretationsClose Below 40W SMA With ProfitabilityCash Backing With OCF Coverage And Cash Near Total Debt
Fortune Electric Co., Ltd.
2 interpretationsClose Below 40W SMA With ProfitabilityCash Backing With OCF Coverage And Cash Near Total Debt